Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Betel, Doron"'
Autor:
Rudloff MW; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA., Favret NR; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Roetman JJ; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Detrés Román CR; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Erwin MM; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Murray KA; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Jonnakuti ST; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA., Dündar F; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA., Betel D; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Philip M; Department of Medicine, Division of Hematology and Oncology, Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA. mary.philip@vumc.org.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, USA. mary.philip@vumc.org.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. mary.philip@vumc.org.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Sep; Vol. 24 (9), pp. 1527-1539. Date of Electronic Publication: 2023 Aug 03.
Autor:
Chandran SS; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandrs1@mskcc.org.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandrs1@mskcc.org.; Parker Institute for Cancer Immunotherapy, New York, NY, USA. chandrs1@mskcc.org., Ma J; Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, IN, USA.; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA., Klatt MG; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dündar F; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA., Bandlamudi C; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Razavi P; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA., Fu SN; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Banks LB; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yi F; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vercher E; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Etxeberria I; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bestman WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Da Cruz Paula A; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aricescu IS; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Betel D; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Baker BM; Department of Chemistry and Biochemistry, University of Notre Dame, South Bend, IN, USA.; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA., Klebanoff CA; Human Oncology and Pathogenesis Program (HOPP), Immuno-Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org.; Parker Institute for Cancer Immunotherapy, New York, NY, USA. klebanoc@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org.; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA. klebanoc@mskcc.org.; Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org.; Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org.
Publikováno v:
Nature medicine [Nat Med] 2022 May; Vol. 28 (5), pp. 946-957. Date of Electronic Publication: 2022 Apr 28.
Autor:
Shakiba M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY., Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY., Espinosa-Carrasco G; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Menocal L; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Dündar F; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY., Carson SE; Department of Biochemistry, Cell and Molecular Biology, Weill Cornell Medicine, New York, NY., Bruno EM; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Sanchez-Rivera FJ; Cancer Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Lowe SW; Cancer Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Camara S; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY., Reuter VP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY., Socci ND; Bioinformatics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY., Whitlock B; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Tamzalit F; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Huse M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY., Hellmann MD; Parker Institute for Cancer Immunotherapy, San Francisco, CA.; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, Cornell University, New York, NY., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Defranoux NA; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Betel D; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY., Philip M; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN., Schietinger A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2022 Feb 07; Vol. 219 (2). Date of Electronic Publication: 2021 Dec 22.
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment.
Autor:
Khan U; Department of Medicine, Division of Hematology/Oncology, New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn., Ho K; Department of Population Health Sciences, Division of Biostatistics., Hwang EK; Joint Clinical Trial Office., Peña C; Joint Clinical Trial Office., Brouwer J; Joint Clinical Trial Office.; Center for Advanced Digestive Care, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY., Hoffman K; Department of Population Health Sciences, Division of Biostatistics., Betel D; Department of Medicine, Division of Hematology/Oncology., Sonnenberg GF; Jill Roberts Institute for Research in Inflammatory Bowel Disease, Division of Gastroenterology., Faltas B; Department of Medicine, Division of Hematology/Oncology., Saxena A; Department of Medicine, Division of Hematology/Oncology., Weisiger KE; Department of Radiology, Division of Body and Breast Imaging., Oh S; Department of Radiology, Division of Body and Breast Imaging., Hissong E; Department of Pathology, Weill Cornell Medicine., RoyChoudhury A; Department of Population Health Sciences, Division of Biostatistics., Shah MA; Department of Medicine, Division of Hematology/Oncology.; Center for Advanced Digestive Care, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
Publikováno v:
American journal of clinical oncology [Am J Clin Oncol] 2021 Jun 01; Vol. 44 (6), pp. 247-253.
Autor:
Scott AC; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA., Dündar F; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA., Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA., Chandran SS; Parker Institute for Cancer Immunotherapy, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Klebanoff CA; Parker Institute for Cancer Immunotherapy, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Shakiba M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Trivedi P; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Menocal L; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA., Appleby H; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Camara S; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zamarin D; Parker Institute for Cancer Immunotherapy, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Walther T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Snyder A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Femia MR; Parker Institute for Cancer Immunotherapy, New York, NY, USA.; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Comen EA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hellmann MD; Parker Institute for Cancer Immunotherapy, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Anandasabapathy N; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.; Department of Dermatology, Weill Cornell Medical College, New York, NY, USA., Liu Y; Department of Dermatology, Weill Cornell Medical College, New York, NY, USA., Altorki NK; Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA., Lauer P; Aduro Biotech, Inc., Berkeley, CA, USA., Levy O; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glickman MS; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA., Kaye J; Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Betel D; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Philip M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mary.philip@vumc.org.; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. mary.philip@vumc.org., Schietinger A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. schietia@mskcc.org.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA. schietia@mskcc.org.; Parker Institute for Cancer Immunotherapy, New York, NY, USA. schietia@mskcc.org.
Publikováno v:
Nature [Nature] 2019 Jul; Vol. 571 (7764), pp. 270-274. Date of Electronic Publication: 2019 Jun 17.
Autor:
Wang Q; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; College of Computing & Technology, Lipscomb University, Nashville, Tennessee 37204, USA., Armenia J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Zhang C; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, 10021, USA., Penson AV; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Reznik E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Zhang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Minet T; College of Computing & Technology, Lipscomb University, Nashville, Tennessee 37204, USA., Ochoa A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Gross BE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Iacobuzio-Donahue CA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Betel D; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, 10021, USA., Taylor BS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Gao J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Schultz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Publikováno v:
Scientific data [Sci Data] 2018 Apr 17; Vol. 5, pp. 180061. Date of Electronic Publication: 2018 Apr 17.